Ascendis Pharma initiates clinical trial of dwarfism drug
![Photo: Kevin Grønnemann](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article11298514.ece/ALTERNATES/schema-16_9/ascendis.jpg)
Ascendis Pharma has initiated a hunt for new patients for a phase II trial in China, according to the Clinical Trials database.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Biomarin projects 2022 Voxzogo sales of USD 115m
For subscribers